DE69617010D1 - Isazole derivate als fibrinogen-rezeptor-antagonisten - Google Patents

Isazole derivate als fibrinogen-rezeptor-antagonisten

Info

Publication number
DE69617010D1
DE69617010D1 DE69617010T DE69617010T DE69617010D1 DE 69617010 D1 DE69617010 D1 DE 69617010D1 DE 69617010 T DE69617010 T DE 69617010T DE 69617010 T DE69617010 T DE 69617010T DE 69617010 D1 DE69617010 D1 DE 69617010D1
Authority
DE
Germany
Prior art keywords
isazole
derivatives
receptor antagonists
fibrinogen receptor
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69617010T
Other languages
English (en)
Other versions
DE69617010T2 (de
Inventor
Eric Olson
John Wityak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE69617010D1 publication Critical patent/DE69617010D1/de
Publication of DE69617010T2 publication Critical patent/DE69617010T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69617010T 1995-05-24 1996-05-24 Isazole derivate als fibrinogen-rezeptor-antagonisten Expired - Fee Related DE69617010T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44959795A 1995-05-24 1995-05-24
US58694096A 1996-01-11 1996-01-11
PCT/US1996/007645 WO1996037482A1 (en) 1995-05-24 1996-05-24 Improved isoxazoline fibrinogen receptor antagonists

Publications (2)

Publication Number Publication Date
DE69617010D1 true DE69617010D1 (de) 2001-12-20
DE69617010T2 DE69617010T2 (de) 2002-06-27

Family

ID=27035737

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69617010T Expired - Fee Related DE69617010T2 (de) 1995-05-24 1996-05-24 Isazole derivate als fibrinogen-rezeptor-antagonisten

Country Status (9)

Country Link
EP (1) EP0832077B1 (de)
JP (1) JPH11511745A (de)
AR (1) AR002996A1 (de)
AT (1) ATE208764T1 (de)
AU (1) AU5876196A (de)
CA (1) CA2222050A1 (de)
DE (1) DE69617010T2 (de)
IL (1) IL118007A0 (de)
WO (1) WO1996037482A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
WO1998006707A1 (en) * 1996-08-15 1998-02-19 Dupont Pharmaceuticals Company Cyclic carbamates and isoxazolidines as iib/iiia antagonists
US5998424A (en) 1997-06-19 1999-12-07 Dupont Pharmaceuticals Company Inhibitors of factor Xa with a neutral P1 specificity group
KR20010013977A (ko) 1997-06-19 2001-02-26 블레어 큐. 퍼거슨 중성 ｐ1 특이성 기를 갖는 인자 ｘａ의 억제제
US6319937B1 (en) * 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
EP0730589B1 (de) * 1993-11-24 1998-07-08 The Du Pont Merck Pharmaceutical Company Isoxazoline derivate anwendbar als fibrinogen rezeptor antagonisten

Also Published As

Publication number Publication date
WO1996037482A1 (en) 1996-11-28
AU5876196A (en) 1996-12-11
DE69617010T2 (de) 2002-06-27
EP0832077A1 (de) 1998-04-01
EP0832077B1 (de) 2001-11-14
IL118007A0 (en) 1996-08-04
ATE208764T1 (de) 2001-11-15
JPH11511745A (ja) 1999-10-12
AR002996A1 (es) 1998-05-27
CA2222050A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
DE69531458D1 (de) Chinolinderivate als tachykinin nk3 rezeptor antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
DE69325167T2 (de) Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
ATE197300T1 (de) Indolderivate als 5-ht rezeptorantagoniste
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
ATE404562T1 (de) Substituierte purinderivate als vitronectinrezeptor-antagonisten
DE69714265D1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE69418045D1 (de) Amidderivate als 5ht1d rezeptor antagonisten
DE69718786T2 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69717449T2 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
ATE206421T1 (de) Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten
FI941118A (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
FI941117A (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina
FI963463A0 (fi) Indolijohdannaiset CCK-reseptoriantagonisteina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee